https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-investigating-possible-increased-risk-death-lymphoma-medicine-ukoniq-umbralisib
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) | FDA
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer...
increased risk